Cardiovascular outcomes and proprotein convertase subtilisin/kexin type 9 inhibitors: Current data and future prospects

Daniel A. Duprez, Yehuda Handelsman, Michael Koren

Research output: Contribution to journalReview articlepeer-review

4 Scopus citations

Fingerprint

Dive into the research topics of 'Cardiovascular outcomes and proprotein convertase subtilisin/kexin type 9 inhibitors: Current data and future prospects'. Together they form a unique fingerprint.

Medicine & Life Sciences

Social Sciences